Aptevo Therapeutics APVO
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 0.31 | 102.40 | -1.67 | -6,024 | -6 | |
| 2024Q1 | 4.69 | 102.18 | -9.95 | -6,983 | -7 | |
| 2023Q4 | 7.96 | 103.03 | -6.16 | -6,384 | -6 | |
| 2023Q3 | 14.52 | 103.58 | -24.64 | -6,560 | -6 | |
| 2023Q2 | 64.24 | 102.89 | 0.58 | -49.06 | -8,178 | -8 |
| 2023Q1 | 89.54 | -424.52 | 0.56 | 17.38 | -7,756 | 3 |
| 2022Q4 | 102.08 | 148.83 | 1.85 | -41.80 | -7,684 | -5 |
| 2022Q3 | 133.76 | 99.68 | 2.42 | -68.63 | -7,784 | -8 |
| 2022Q2 | 157.52 | -27.14 | 2.54 | 247.69 | -7,562 | 28 |
| 2022Q1 | 258.28 | 71.25 | -68.19 | -5,611 | -8 | |
| 2021Q4 | 346.28 | 61.24 | -55.87 | -4,040 | -6 | |
| 2021Q3 | 679.37 | 67.12 | -62.03 | -4,750 | -7 | |
| 2021Q2 | 986.93 | 70.96 | -76.99 | -5,722 | -8 | |
| 2021Q1 | 1342.90 | 89.80 | -72.15 | -6,888 | -7 | |
| 2020Q4 | 1612.62 | 95.09 | -84.48 | -6,819 | -7 | |
| 2020Q3 | 334.40 | 89.90 | -93.28 | -6,246 | -7 | |
| 2020Q2 | 367.40 | 100.06 | -91.52 | -6,807 | -7 | |
| 2020Q1 | 162.80 | 76.21 | 39.16 | -7,622 | 3 | |
| 2019Q4 | 28.80 | 95.39 | -104.72 | -9,570 | -8 | |
| 2019Q3 | 25.89 | 95.52 | -75.68 | -13,319 | -7 |